Form 4: Elevance Health Director Ryan M. Schneider Reports Acquisition of Deferred Stock Units

Director Ryan M. Schneider reported the acquisition of 601 deferred stock units of Elevance Health, Inc. on May 14, 2025.

Summary

• On May 14, 2025, Ryan M. Schneider, a director of Elevance Health, Inc., acquired 601 deferred stock units.
• These units were accrued under the Elevance Health, Inc. Board of Directors Compensation Program.
• The deferred stock units will be payable in company common stock either five years from the grant date or upon cessation of board membership, unless a later date is designated.
• Following the transaction, Schneider beneficially owns 6,600 shares of common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing regarding stock ownership, and does not contain information that would significantly sway investor sentiment positively or negatively.

Future Outlook

The deferred stock units will be payable in company common stock either five years from the grant date or upon cessation of board membership, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Industry Context

This filing is a routine disclosure related to director compensation and stock ownership, common in publicly traded companies. It provides transparency into the alignment of director interests with shareholder value.

Stakeholder Impact

• The acquisition of deferred stock units by a director aligns their interests with those of shareholders, potentially encouraging decisions that increase shareholder value.

Key Dates

Keywords

Elevance Health, Director, Ryan M. Schneider, Deferred Stock Units, Beneficial Ownership, Form 4, ELV